Projecting future drug expenditures--2007
- PMID: 17244880
- DOI: 10.2146/ajhp060545
Projecting future drug expenditures--2007
Abstract
Purpose: Drug expenditure trends in 2005 and 2006, projected drug expenditures for 2007, and factors likely to influence drug costs are discussed.
Summary: Various factors are likely to affect drug costs, including drug prices, drugs in development, and generic drugs. In 2005, there was a continued moderation of the increase in drug expenditures. Total prescription drug expenditures increased by 5.5% from 2004 to 2005, with total spending rising from $239 billion to $252 billion. Through the first nine months of 2006, hospital drug expenditures increased by only 3% compared with 2005. This moderation of the growth of prescription drug expenditures can be attributed to three major factors: availability of major prescription drugs in generic form, continued increase in cost sharing for employees in employer-sponsored health plans, and decreased use due to safety concerns. It is expected that expenditures in 2007 will be influenced by similar factors, with few costly new products reaching the market, increased concern over product safety reducing the use of older agents and slowing the diffusion of newer agents that do reach the market, and several important patent expirations, leading to slower growth in expenditures.
Conclusion: In 2007, we project a 5-7% increase in drug expenditures in outpatient settings, a 14-16% increase in clinics, and a 4-6% increase in hospitals.
Similar articles
-
Projecting future drug expenditures--2006.Am J Health Syst Pharm. 2006 Jan 15;63(2):123-38. doi: 10.2146/ajhp050446. Am J Health Syst Pharm. 2006. PMID: 16390926
-
Projecting future drug expenditures--2005.Am J Health Syst Pharm. 2005 Jan 15;62(2):149-67. doi: 10.1093/ajhp/62.2.149. Am J Health Syst Pharm. 2005. PMID: 15700889 Review.
-
Projecting future drug expenditures--2012.Am J Health Syst Pharm. 2012 Mar 1;69(5):405-21. doi: 10.2146/ajhp110697. Am J Health Syst Pharm. 2012. PMID: 22345420
-
Projecting future drug expenditures--2010.Am J Health Syst Pharm. 2010 Jun 1;67(11):919-28. doi: 10.2146/ajhp100068. Am J Health Syst Pharm. 2010. PMID: 20484216
-
Projecting future drug expenditures--2004.Am J Health Syst Pharm. 2004 Jan 15;61(2):145-58. doi: 10.1093/ajhp/61.2.145. Am J Health Syst Pharm. 2004. PMID: 14750400 Review.
Cited by
-
The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: comparison with diazepam.Psychopharmacology (Berl). 2014 Aug;231(15):2967-79. doi: 10.1007/s00213-014-3473-x. Epub 2014 Feb 15. Psychopharmacology (Berl). 2014. PMID: 24531568
-
Antimicrobial stewardship in acute care centres: A survey of 68 hospitals in Quebec.Can J Infect Dis Med Microbiol. 2008 May;19(3):237-42. doi: 10.1155/2008/845651. Can J Infect Dis Med Microbiol. 2008. PMID: 19412381 Free PMC article.
-
Trends in pharmaceutical expenditures: the impact on drug benefit design.Am Health Drug Benefits. 2008 May;1(4):29-34. Am Health Drug Benefits. 2008. PMID: 25126231 Free PMC article.
-
Accuracy of annual prescription drug expenditure forecasts in AJHP.Am J Health Syst Pharm. 2015 Oct 1;72(19):1642-8. doi: 10.2146/ajhp140850. Am J Health Syst Pharm. 2015. PMID: 26386105 Free PMC article.
-
Financial Consequences of Improved Treatments for Colorectal Cancer.Semin Colon Rectal Surg. 2008 Dec 1;19(4):247-252. doi: 10.1053/j.scrs.2008.09.010. Semin Colon Rectal Surg. 2008. PMID: 19956780 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources